𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of long-term oral levodopa therapy in chronic congestive heart failure

✍ Scribed by Hasenfuss, G. ;Kasper, W. ;Meinertz, Th. ;Busch, W. ;Lehmann, M. ;Krause, Th. ;Hofmann, Th. ;Revenaugh, M. ;Holubarsch, Ch. ;Just, H.

Publisher
Springer-Verlag
Year
1987
Tongue
English
Weight
865 KB
Volume
65
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can intravenous beta blockade predict lo
Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol
✍ DasGupta, P. ;Lahiri, A. πŸ“‚ Article πŸ“… 1992 πŸ› Springer-Verlag 🌐 English βš– 694 KB

Several studies in the past have shown the long-term beneficial effects of beta-blockers in congestive heart failure. Despite the interest in this mode of therapy, their clinical application has been limited due to their negative inotropic effect. A subset of the heart failure patients do not show a

Isometric exercise for the evaluation of
Isometric exercise for the evaluation of vasodilatory therapy in severe congestive heart failure
✍ Frank F. Hertrich; Bernhard R. Winkelmann; Hans Leinberger πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 437 KB

There are few data available about the hemodynamic effects of isometric handgrip in severe congestive heart failure and its role in the evaluation of vasodilatory therapy. Therefore, we studied 20 patients with dilated cardiomyopathy at rest, during isometric handgrip, and during supine bicycle exer

Haemodynamic evaluation of two regimens
Haemodynamic evaluation of two regimens of molsidomine in patients with chronic congestive heart failure
✍ G. Lehmann; G. Reiniger; A. Beyerle; H. Zeitler; W. Rudolph πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 589 KB

We investigated the extent and duration of the haemodynamic effects of two regimens of molsidomine, i.e. two tablets of a standard regimen consisting of 4 mg given 6 h apart and one tablet of 16 mg in sustained-release form once daily in 13 patients with chronic congestive heart failure using a plac